JULIE KULAWY: Open Payments
NPI 1730867565 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,785 in 100 payments from 22 companies in 2025. Trend: 2023 $377 · 2024 $1,639 · 2025 $2,785
Food & beverage: $2,785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $754 |
| AstraZeneca Pharmaceuticals LP | 13 | $611 |
| Amgen Inc. | 14 | $234 |
| Novo Nordisk Inc | 6 | $220 |
| PFIZER INC. | 9 | $208 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $182 |
| ALK-Abello, Inc | 4 | $80 |
| Lilly USA, LLC | 4 | $78 |
| Dexcom, Inc. | 3 | $72 |
| Optinose US, Inc. | 3 | $65 |
Products named: QULIPTA, AIRSUPRA, BREZTRI, VRAYLAR, XIFAXAN, Ozempic, OTEZLA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
